UBS Group’s OSR Health OSRH Stock Holding History

UBS Group’s Portfolio OSRH Stock Details OSRH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$183	Sell	580 -3,896	-87%	-$1.95K	﹤0.01%	10020
2026 Q1	$2.7K	Sell	4,476 -6,824	-60%	-$3.69K	﹤0.01%	9217
2025 Q4	$6.37K	Buy	+11,300	New	+$6.98K	﹤0.01%	8560
2025 Q3	–	Sell	-24,407	Closed	-$33.7K	–	11277
2025 Q2	$33.7K	Buy	+24,407	New	+$33.9K	﹤0.01%	8082
2025 Q1	–	Sell	-5	Closed	-$56	–	10935
2024 Q4	$56	Sell	5 -214	-98%	-$2.4K	﹤0.01%	9694
2024 Q3	$2.38K	Buy	219 +133	+155%	+$1.44K	﹤0.01%	8443
2024 Q2	$925	Sell	86 -5	-5%	-$54	﹤0.01%	8731
2024 Q1	$970	Buy	+91	New	+$966	﹤0.01%	8288
2023 Q4	–	Sell	-109	Closed	-$1.13K	–	10029
2023 Q3	$1.13K	Buy	+109	New	+$1.13K	﹤0.01%	8081
2023 Q2	–	Sell	-8,100	Closed	-$81.8K	–	9811
2023 Q1	$81.8K	Buy	+8,100	New	+$81.8K	﹤0.01%	6081

Other funds holding OSRH

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group's OSRH Position: Q2 2026 in Review

UBS Group reduced its OSR Health (OSRH) stake by 87% in Q2 2026, selling an estimated $1.95K and leaving 580 shares worth $183. The position accounts for ﹤0.01% of the portfolio, ranked #10020.

UBS Group first reported a position in OSRH in Q1 2023 and has held it in 10 quarters since. The position peaked at $81.8K in Q1 2023. 13 funds tracked by Wall St. Rank hold OSRH as of Q2 2026.

UBS Group held 580 shares of OSR Health worth $183 as of Q2 2026.
UBS Group sold 3,896 OSR Health shares in Q2 2026, an estimated $1.95K.
OSR Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10020 holding.
UBS Group first reported a position in OSR Health in Q1 2023 and has held it in 10 quarters since.
UBS Group's OSR Health position peaked at $81.8K in Q1 2023.
13 funds tracked by Wall St. Rank held OSR Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.